Advanced search
Publication Cover
Patient Preference and Adherence Volume 12, 2018 - Issue
Submit an article Journal homepage
191
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension

Evan W Davies1 Actelion Pharmaceuticals Ltd., Allschwil, SwitzerlandCorrespondence[email protected]
,
Samuel Llewellyn2 ICON plc, Abingdon, UK
,
Amélie Beaudet1 Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
,
Charlotte E Kosmas2 ICON plc, Abingdon, UK
,
Wendy Gin-Sing3 Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
&
Helen A Doll2 ICON plc, Abingdon, UK
Pages 1079-1088 | Published online: 21 Jun 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Beenish Nafees, Hayley M de Freitas, Amélie Beaudet, Eunju Todd & Wendy Gin-Sing. (2023) A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension. Patient Preference and Adherence 17, pages 2119-2130.
Read now

Articles from other publishers (7)

Yuqiong Lu, Zhanjing Dai, Feng Chang, Li Wang, Jiafang He, Penghua Shi, Haitao Zhang & Yun Lu. (2023) Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment. PharmacoEconomics 41:3, pages 295-306.
Crossref
Xiaopei Cui, Weida Lu, Deyuan Zhang, Liangyi Qie, Haijun Li, Xiao Li, Hui Liu & Qiushang Ji. (2022) Selexipag-based triple combination therapy improves prognosis in Chinese pulmonary arterial hypertension patients. Frontiers in Cardiovascular Medicine 9.
Crossref
Ci Song, Peter Kunovszki & Amélie Beaudet. (2022) Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis. Journal of Health Economics and Outcomes Research 9:1, pages 151-160.
Crossref
Ci Song, Peter Kunovszki & Amélie Beaudet. (2022) Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis. Journal of Health Economics and Outcomes Research 9:1.
Crossref
Louis S. Matza, Katie D. Stewart, Andrew J. Lloyd, Donna Rowen & John E. Brazier. (2021) Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations. Value in Health 24:6, pages 812-821.
Crossref
Shelley Shapiro, Robert C. Bourge, Patti Pozella, David F. Harris, Erick H. Borg & Andrew C. Nelsen. (2020) Implantable system for treprostinil: a real‐world patient experience study. Pulmonary Circulation 10:2, pages 1-10.
Crossref
Bo Sun, Weijun Wang, Zhibin He, Min Zhang, Fangong Kong & Mohini Sain. (2020) Biopolymer Substrates in Buccal Drug Delivery: Current Status and Future Trend. Current Medicinal Chemistry 27:10, pages 1661-1669.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.